v3.22.2.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Cash flows from operating activities    
Net loss $ (14,919) $ (1,468)
Adjustments to reconcile net loss to net cash from operating activities:    
Depreciation, amortization and accretion 20,819 14,167
Unrealized gain on interest rate swaps (2,387) (356)
Deferred tax expense 2,370 (1,517)
Loss on extinguishment of debt 0 3,245
Amortization of debt discount and financing costs 2,151 2,165
Change in fair value of redeemable warrant liability 6,447 0
Change in fair value of alignment shares liability 9,367 0
Remeasurement of contingent consideration (146) (2,400)
Gain on disposal of property, plant and equipment (2,222) 0
Stock-based compensation 6,670 111
Other (171) (232)
Changes in assets and liabilities, excluding the effect of acquisitions    
Accounts receivable (6,405) (2,384)
Other assets 2,927 (148)
Accounts payable (1,209) 6,221
Interest payable (2) 566
Other liabilities 1,549 278
Net cash provided by operating activities 24,839 18,248
Cash flows used for investing activities    
Capital expenditures (35,670) (10,255)
Payments to acquire businesses, net of cash and restricted cash acquired 0 (192,565)
Payments to acquire renewable energy facilities from third parties, net of cash and restricted cash acquired (13,342) (10,673)
Proceeds from disposal of property, plant and equipment 3,605 0
Other 496 0
Net cash used for investing activities (44,911) (213,493)
Cash flows used for financing activities    
Proceeds from issuance of long-term debt 0 288,922
Repayment of long-term debt (13,301) (148,790)
Payment of debt issuance costs (68) (2,247)
Payment of debt extinguishment costs 0 (1,477)
Payment of dividends and commitment fees on Series A preferred stock 0 (17,748)
Payment of deferred transaction costs 0 (4,254)
Payment of contingent consideration (72) (129)
Payment of equity issuance costs (744) 0
Proceeds from issuance of Series A preferred stock 0 82,000
Cash proceeds from public warrant exercise 19 0
Contributions from noncontrolling interests 3,220 2,708
Distributions to noncontrolling interests (1,914) (1,938)
Redemption of noncontrolling interests 0 (831)
Net cash (used for) provided by financing activities (12,860) 196,216
Net (decrease) increase in cash, cash equivalents, and restricted cash (32,932) 971
Cash, cash equivalents, and restricted cash, beginning of period 330,321 38,206
Cash, cash equivalents, and restricted cash, end of period 297,389 39,177
Supplemental cash flow disclosure    
Cash paid for interest, net of amounts capitalized 14,927 11,404
Cash paid for taxes 99 99
Non-cash investing and financing activities    
Asset retirement obligations 276 2,391
Debt assumed through acquisitions 11,948 0
Redeemable noncontrolling interest assumed through acquisitions 2,125 0
Acquisitions of property and equipment included in other current liabilities 4,004 622
Deferred transaction costs not yet paid 0 2,801
Accrued dividends and commitment fees on Series A preferred stock 0 13,584
Construction loan conversion (4,186) 0
Term loan conversion 4,186 0
Conversion of alignment shares into common stock 15 0
Exchange of warrants into common stock 7,779 0
Warrants exercised on a cashless basis $ 35,858 $ 0